TLX101-Px is also being developed as a patient selection and response assessment tool for Telix’s glioblastoma therapy candidate TLX101-Tx (iodofalan 131 I), which has been granted orphan drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results